Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin

Virology

Volumn 458-459, Issue 1, 2014, Pages 114-124

  Wilson, Jason R ^a   Tzeng, Wen Pin ^a   Spesock, April ^a,c   Music, Nedzad ^a   Guo, Zhu ^a   Barrington, Robert ^b   Stevens, James ^a   Donis, Ruben O ^a   Katz, Jacqueline M ^a   York, Ian A ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Affinity; Antibody; Cloning; Germline; Influenza; Repertoire

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; EMBRYO; FEMALE; GENETIC VARIABILITY; HEMAGGLUTINATION; HUMAN; HUMAN CELL; IGH GENE; IGL GENE; IMMUNOGLOBULIN VARIABLE REGION; INFLUENZA VIRUS A H1N1; MOLECULAR CLONING; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; VDJ EXON; VIRUS STRAIN;

AFFINITY; ANTIBODY; CLONING; GERMLINE; INFLUENZA; REPERTOIRE;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULINS; INFLUENZA VACCINES; MICE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84899985322     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.011     Document Type: Article

References (56)

1. Burnham K.P., Overton W.S. Estimation of the size of a closed population when capture probabilities vary among animals. Biometrika 1978, 65:625-633.
2. Burnham K.P., Overton W.S. Robust estimation of population size when capture probabilities vary among animals. Ecology 1979, 60:927-936.
3. de Bono B., Madera M., Chothia C. VH gene segments in the mouse and human genomes. J. Mol. Biol. 2004, 342:131-143.
4. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31:417-427.
5. Caton A.J., Stark S.E., Kavaler J., Staudt L.M., Schwartz D., Gerhard W. Many variable region genes are utilized in the antibody response of BALB/c mice to the influenza virus A/PR/8/34 hemagglutinin. J. Immunol. 1991, 147:1675-1686.
6. Chao A. Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 1984, 11:265-270.
7. Chao A., Bunge J. Estimating the number of species in a stochastic abundance model. Biometrics 2002, 58:531-539.
8. Chao A., Lee S.-M. Estimating the number of classes via sample coverage. J. Am. Stat. Assoc. 1992, 87:210-217.
9. Chen L.M., Rivailler P., Hossain J., Carney P., Balish A., Perry I., Davis C.T., Garten R., Shu B., Xu X., Klimov A., Paulson J.C., Cox N.J., Swenson S., Stevens J., Vincent A., Gramer M., Donis R.O. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 2011, 412:401-410.
10. Co M.D., Cruz J., Takeda A., Ennis F.A., Terajima M. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals. Human Vaccines Immunother. 2012, 8:1218-1222.
11. Corti D., Suguitan A.L., Pinna D., Silacci C., Fernandez-Rodriguez B.M., Vanzetta F., Santos C., Luke C.J., Torres-Velez F.J., Temperton N.J., Weiss R.A., Sallusto F., Subbarao K., Lanzavecchia A. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 2010, 120:1663-1673.
12. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B.M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L.F., Temperton N., Langedijk J.P., Skehel J.J., Lanzavecchia A. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.
13. Daniels R.S., Jeffries S., Yates P., Schild G.C., Rogers G.N., Paulson J.C., Wharton S.A., Douglas A.R., Skehel J.J., Wiley D.C. The receptor-binding and membrane-fusion properties of influenza-virus variants selected using anti-hemagglutinin monoclonal-antibodies. EMBO J. 1987, 6:1459-1465.
14. Davis M.M., Lyons D.S., Altman J.D., McHeyzer-Williams M., Hampl J., Boniface J.J., Chien Y. T cell receptor biochemistry, repertoire selection and general features of TCR and Ig structure. Ciba Found. Symp. 1997, 204:94-100. (discussion 100-104).
15. Dreyfus C., Laursen N.S., Kwaks T., Zuijdgeest D., Khayat R., Ekiert D.C., Lee J.H., Metlagel Z., Bujny M.V., Jongeneelen M., van der Vlugt R., Lamrani M., Korse H.J., Geelen E., Sahin O., Sieuwerts M., Brakenhoff J.P., Vogels R., Li O.T., Poon L.L., Peiris M., Koudstaal W., Ward A.B., Wilson I.A., Goudsmit J., Friesen R.H. Highly conserved protective epitopes on influenza B viruses. Science 2012, 337:1343-1348.
16. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
17. Ekiert D.C., Friesen R.H., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., Vogels R., Brakenhoff J.P., Kompier R., Koldijk M.H., Cornelissen L.A., Poon L.L., Peiris M., Koudstaal W., Wilson I.A., Goudsmit J. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333:843-850.
18. Ekiert D.C., Kashyap A.K., Steel J., Rubrum A., Bhabha G., Khayat R., Lee J.H., Dillon M.A., O'Neil R.E., Faynboym A.M., Horowitz M., Horowitz L., Ward A.B., Palese P., Webby R., Lerner R.A., Bhatt R.R., Wilson I.A. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 2012, 489:526-532.
19. Ellebedy A.H., Webby R.J. Influenza vaccines. Vaccine 2009, 27(Suppl. 4):D65-D68.
20. Grohskopf L., Uyecki T., Bresee J., Cox N., Shimabukuro T. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR 2012, 61:613-618.
21. Jegaskanda S., Weinfurter J.T., Friedrich T.C., Kent S.J. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of Macaques. J. Virol. 2013, 87:5512-5522.
22. Jegaskanda S., Job E.R., Kramski M., Laurie K., Isitman G., de Rose R., Winnall W.R., Stratov I., Brooks A.G., Reading P.C., Kent S.J. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J. Immunol. 2013, 190:1837-1848.
23. Johnston C.M., Wood A.L., Bolland D.J., Corcoran A.E. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J. Immunol. 2006, 176:4221-4234.
24. Katz J.M., Hancock K., Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti. Infect. Ther. 2011, 9:669-683.
25. Katz J.M., Hancock K., Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti. Infect. Ther. 2011, 9:669-683.
26. Khurana S., Loving C.L., Manischewitz J., King L.R., Gauger P.C., Henningson J., Vincent A.L., Golding H., 2013. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease. Sci. Transl. Med. 5 (200), p. 200ra114, http://dx.doi.org/10.1126/scitranslmed.3006366.
27. Krause J.C., Tumpey T.M., Huffman C.J., McGraw P.A., Pearce M.B., Tsibane T., Hai R., Basler C.F., Crowe J.E. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J. Virol. 2010, 84:3127-3130.
28. Laeeq S., Smith C.A., Wagner S.D., Thomas D.B. Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene. J. Virol. 1997, 71:2600-2605.
29. Lefranc M.-P., Giudicelli V., Ginestoux C., Jabado-Michaloud J., Folch G., Bellahcene F., Wu Y., Gemrot E., Brochet X., Lane J., Regnier L., Ehrenmann F., Lefranc G., Duroux P. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2009, 37:D1006-D1012.
30. Lingwood D., McTamney P.M., Yassine H.M., Whittle J.R.R., Guo X., Boyington J.C., Wei C.-J., Nabel G.J. Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 2012, 489:566-570.
31. McLain L., Dimmock N.J. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. J. Gen. Virol. 1989, 70(Part 10):2615-2624.
32. Molinari N-AM, Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., Bridges C.B. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
33. Okuno Y., Isegawa Y., Sasao F., Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 1993, 67:2552-2558.
34. Schroeder H.W. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev. Comp. Immunol. 2006, 30:119-135.
35. Seidl K.J., MacKenzie J.D., Wang D., Kantor A.B., Kabat E.A., Herzenberg L.A., Herzenberg L.A. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int. Immunol. 1997, 9:689-702.
36. Srivastava V., Yang Z., Hung I.F., Xu J., Zheng B., Zhang M.Y. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus. J. Virol. 2013, 87:5831-5840.
37. Staudt L.M., Gerhard W. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J. Exp. Med. 1983, 157:687-704.
38. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
39. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
40. Temoltzin-Palacios F., Thomas D.B. Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses. J. Exp. Med. 1994, 179:1719-1724.
41. Terajima M., Cruz J., Co M.D., Lee J.H., Kaur K., Wrammert J., Wilson P.C., Ennis F.A. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies. J. Virol. 2011, 85:13463-13467.
42. Thompson M., Shay D., Zhou H., Bridges C., Cheng P., Burns M., Bresee J., Cox N. Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR 2010, 59.
43. Throsby M., Van Den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., Bakker A., Cox F., Van Deventer E., Guan Y., Cinatl J., Ter Meulen J., Lasters I., Carsetti R., Peiris M., De Kruif J., Goudsmit J. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 2008, 3:e3942.
44. Tiller T., Busse C.E., Wardemann H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 2009, 350:183-193.
45. To K.K., Zhang A.J., Hung I.F., Xu T., Ip W.C., Wong R.T., Ng J.C., Chan J.F., Chan K.H., Yuen K.Y. High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clin. Vaccine Immunol.: CVI 2012, 19:1012-1018.
46. Wang J.P. Estimating species richness by a Poisson-compound gamma model. Biometrika 2010, 97:727-740.
47. Wang J.P. SPECIES: an R package for species richness estimation. J. Stat. Softw. 2011, 40:1-15.
48. Wang J.P.Z., Lindsay B.G. Penalized nonparametric maximum likelihood approach to species richness estimation. J. Am. Stat. Assoc. 2005, 100:942-959.
49. Whittle J.R., Zhang R., Khurana S., King L.R., Manischewitz J., Golding H., Dormitzer P.R., Haynes B.F., Walter E.B., Moody M.A., Kepler T.B., Liao H.X., Harrison S.C. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 2011, 108:14216-14221.
50. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981, 289:373-378.
51. World Health Organization Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza 2011.
52. Wrammert J., Koutsonanos D., Li G.M., Edupuganti S., Sui J., Morrissey M., McCausland M., Skountzou I., Hornig M., Lipkin W.I., Mehta A., Razavi B., Del Rio C., Zheng N.Y., Lee J.H., Huang M., Ali Z., Kaur K., Andrews S., Amara R.R., Wang Y., Das S.R., O'Donnell C.D., Yewdell J.W., Subbarao K., Marasco W.A., Mulligan M.J., Compans R., Ahmed R., Wilson P.C. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181-193.
53. Xu J.L., Davis M.M. Diversity in the CDR3 region of VH is sufficient for most antibody specificities. Immunity 2000, 13:37-45.
54. Yang H., Carney P., Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2010, 2:RRN1152.
55. Yewdell J.W., Caton A.J., Gerhard W. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J. Virol. 1986, 57:623-628.
56. Yoshida R., Igarashi M., Ozaki H., Kishida N., Tomabechi D., Kida H., Ito K., Takada A. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog. 2009, 5:e1000350.